Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome-Reference-Cited by-同舟云学术

Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome

Published:2023-01 Issue: Volume:444 Page:120512
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Min Young Gi,Ju Woohee,Seo Jae-Woo,Ha Ye-Eun,Ban Jae-Jun,Kwon Young Nam,Jeong Han-Yeong,Shin Je-Young,Kim Sung-Min,Hong Yoon-Ho,Kim Sang-Jeong,Sung Jung-Joon

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference56 articles.

1. Epidemiological features and economic burden of Guillain-Barre Syndrome in South Korea: A nationwide population-based study;Kim;J Clin Neurol,2021

2. Predicting outcome in Guillain-Barre Syndrome: international validation of the modified erasmus GBS outcome score;Doets;Neurology,2022

3. Diagnosis and management of Guillain-Barre syndrome in ten steps;Leonhard;Nat. Rev. Neurol.,2019

4. Early recognition of poor prognosis in Guillain-Barre syndrome;Walgaard;Neurology,2011

5. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group, (0140–6736 (Print));Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurosymptoms of COVID-19: results of cerebrospinal fluid and blood biomarkers and assessment of diagnostic efficacy of risk factors;2023-10-28

2. Current Biomarker Strategies in Autoimmune Neuromuscular Diseases;Cells;2023-10-15

3. Therapeutic issues in Guillain–Barré syndrome;Expert Review of Neurotherapeutics;2023-05-09